DEA Reviews Scottsdale Research Institute Bulk Manufacturer Application
February 13, 2026
February 13, 2026
WASHINGTON, Feb. 13 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration announced that Scottsdale Research Institute, Phoenix, Arizona, has applied for registration as a bulk manufacturer of specific Schedule I controlled substances.
The application covers the following substances:
* Psilocybin
* Psilocyn
The company intends to manufacture these substances for internal research purposes and to provide support for clinical . . .
The application covers the following substances:
* Psilocybin
* Psilocyn
The company intends to manufacture these substances for internal research purposes and to provide support for clinical . . .